Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Cognitive Correlates of Substance Abuse - 11

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified December 2002 by National Institute on Drug Abuse (NIDA).
Recruitment status was:  Active, not recruiting
Sponsor:
Information provided by:
National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:
NCT00000346
First received: September 20, 1999
Last updated: November 1, 2016
Last verified: December 2002
  Purpose
The purpose of this study is to characterize the cognitive performance of methamphetamine abusers by comparing them with cocaine abusers and normal controls.

Condition Intervention Phase
Amphetamine-Related Disorders
Behavioral: counseling
Phase 4

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Cognitive Correlates of Substance Abuse, Part 1

Further study details as provided by National Institute on Drug Abuse (NIDA):

Estimated Enrollment: 80
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

M/F . Meet DSM-IV criteria for cocaine or methamphetamine dependence. Agree to conditions of the study and sign informed consent.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000346

Locations
United States, California
Friends Research Institute
Los Angeles, California, United States, 90025
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Walter Ling, M.D. Friends Research Institute, Inc.
  More Information

ClinicalTrials.gov Identifier: NCT00000346     History of Changes
Other Study ID Numbers: NIDA-3-0010-11  Y01-3-0010-11 
Study First Received: September 20, 1999
Last Updated: November 1, 2016
Health Authority: United States: Federal Government

Keywords provided by National Institute on Drug Abuse (NIDA):
amphetamine dependence

Additional relevant MeSH terms:
Substance-Related Disorders
Amphetamine-Related Disorders
Chemically-Induced Disorders
Mental Disorders

ClinicalTrials.gov processed this record on December 07, 2016